Author:
Cocuzza Anthony J.,Chidester Dennis R.,Cordova Beverly C.,Jeffrey Susan,Parsons Rodney L.,Bacheler Lee T.,Erickson-Viitanen Susan,Trainor George L.,Ko Soo S.
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference9 articles.
1. L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase
2. Panel on Clinical Practices for the Treatment of HIV Infection. Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents. 28 January 2000; http://www.hivatis.org
3. Bacheler, L.; Weislow, O.; Snyder, S.; Hanna, G.; D'Aquila, R.; the SUSTIVA Resistance Study Team. Abstract, presented at the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, 24–27 September 1998.
4. Synthesis and evaluation of analogs of Efavirenz (SUSTIVATM) as HIV-1 reverse transcriptase inhibitors
5. Synthesis and evaluation of benzoxazinones as HIV-1 reverse transcriptase inhibitors. Analogs of Efavirenz (SUSTIVATM)
Cited by
85 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献